EARLY PREDICTION OF SUSTAINED VIROLOGIC RESPONSE BY HCV CORE ANTIGEN KINETICS IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON PLUS RIBAVIRIN

被引：0
|
作者：
Ricco, G. [1 ]
Moriconi, F. [1 ]
Colombatto, P. [1 ]
Oliveri, F. [1 ]
Cavallone, D. [1 ]
Ciccorossi, P. [1 ]
Coco, B. [1 ]
Romagnoli, V. [1 ]
Rastelli, C. [1 ]
Cherubini, B. [1 ]
Surace, L. [1 ]
Bonino, F. [2 ,3 ]
Galli, C. [4 ]
Brunetto, M. R. [1 ]
机构：
[1] Univ Hosp Pisa, Hepatol Unit, Pisa, Italy
[2] Univ Hosp Pisa, Gen Med Unit 2, Pisa, Italy
[3] Univ Hosp Pisa, Gastroenterol Chair, Pisa, Italy
[4] Abbott Diagnost Div, Rome, Italy
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)61362-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1202
引用
收藏
页码：S488 / S489
页数：2
相关论文
共 50 条
  • [1] EARLY PREDICTION OF SUSTAINED VIROLOGIC RESPONSE BY HCV CORE AG KINETICS IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON PLUS RIBAVIRIN
    Ricco, G.
    Moriconi, F.
    Colombatto, P.
    Oliveri, F.
    Cavallone, D.
    Ciccorossi, P.
    Coco, B.
    Romagnoli, V.
    Rastelli, C.
    Cherubini, B.
    Surace, L.
    Bonino, F.
    Galli, C.
    Brunetto, M. R.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E46 - E46
  • [2] A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
    Swain, Mark G.
    Lai, Ming-Yang
    Shiffman, Mitchell L.
    Cooksley, W. Graham E.
    Zeuzem, Stefan
    Dieterich, Douglas T.
    Abergel, Armand
    Pessoa, Mario G.
    Lin, Amy
    Tietz, Andreas
    Connell, Edward V.
    Diago, Moises
    GASTROENTEROLOGY, 2010, 139 (05) : 1593 - 1601
  • [3] Sustained virologic response (SVR) in liver transplant recipients with hepatitis C (HCV) treated with peginterferon (PEG) and ribavirin (RBV).
    Gordon, Fredric D.
    Morin, Denise
    Simpson, Maryann
    Davis, Carole
    Khettry, Urmila
    Yeh, Frank
    Pomposelli, James J.
    Pomfret, Elizabeth A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 372 - 372
  • [4] Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    Davis, GL
    Wong, JB
    McHutchison, JG
    Manns, MP
    Harvey, J
    Albrecht, J
    HEPATOLOGY, 2003, 38 (03) : 645 - 652
  • [5] Prediction of Treatment Week Eight Response & Sustained Virologic Response in Patients Treated with Boceprevir Plus Peginterferon Alfa and Ribavirin
    Thompson, Alex
    Devine, Scott
    Kattan, Mike
    Muir, Andrew
    PLOS ONE, 2014, 9 (08):
  • [6] Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C
    Di Bisceglie, A. M.
    Ghalib, R. H.
    Hamzeh, F. M.
    Rustgi, V. K.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 721 - 729
  • [7] HCV genotype does not predict sustained virologic response to interferon plus ribavirin in chronic hepatitis C patients with advanced fibrosis
    Cheinquer, H
    Coelho-Borges, S
    Cheinquer, N
    Sander, G
    Rezende, V
    Hadlich, E
    Stifft, J
    JOURNAL OF HEPATOLOGY, 2002, 36 : 230 - 230
  • [8] Rapid virologic response to peginterferon alfa and ribavirin treatment of chronic hepatitis C predicts sustained virologic response and relapse
    Poordad, F. Fred
    Kambili, Chrispin
    GASTROENTEROLOGY, 2008, 134 (04) : A830 - A830
  • [9] DURABILITY OF SUSTAINED VIROLOGIC RESPONSE IN COMBINATION THERAPY WITH INTERFERON/PEGINTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C
    Il Lee, Jung
    Lee, Jin-Woo
    Kim, Young Soo
    Shin, Yong Woon
    Lee, Don Hoeng
    Kim, Hyung Gil
    Jeong, Seok
    Park, Hyung Joo
    Park, Hyun Shin
    Hong, Soon-Sun
    HEPATOLOGY, 2008, 48 (04) : 906A - 907A
  • [10] Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon α-2b and ribavirin
    Gallegos-Orozco, JF
    Loaeza-del Castillo, A
    Fuentes, AP
    García-Sandoval, M
    Soto, L
    Rodríguez, R
    Gutiérrez-Ruíz, MC
    Gutiérrez-Reyes, G
    Bonder, A
    Olivera, MA
    Kershenobich, D
    LIVER INTERNATIONAL, 2005, 25 (01) : 91 - 95
12345